Fractyl Health Inc
(NAS:GUTS)
$
0.70
+0.0080 (+1.15%)
Market Cap: 111.04 Mil
Enterprise Value: 108.69 Mil
PE Ratio: 0
PB Ratio: 5.18
GF Score: 11/100 Fractyl Health Inc at Bank of America Global Healthcare Conference Transcript
May 14, 2026 / 04:20PM GMT
Release Date Price:
$0.954
(+0.60%)
Jason Gerberry
Bofa Merrill Lynch Asset Holdings Inc - Analyst
Good day, everybody. We're going to get going here at the BofA Annual Healthcare Conference and our last company presentation with Fractyl Health. My name is Jason Gerberry. I cover pharma and biotech here at BofA, and we're joined by Harith Rajagopalan, Co-Founder, CEO, and Lara Smith Weber, CFO. Thank you both for joining us here at the conference.
Harith Rajagopalan
Fractyl Health Inc - Chief Executive Officer
Glad to be here. Thanks.
Questions & Answers
Jason Gerberry
Bofa Merrill Lynch Asset Holdings Inc - Analyst
Maybe just get things started with a little bit about Revita, your lead program, and a little bit of the why, if you will. what you're looking to solve for, how you're looking to improve upon outcomes for individuals with obesity.
Harith Rajagopalan
Fractyl Health Inc - Chief Executive Officer
Sure. Revita is a duodenal mucosal resurfacing. It's a catheter-based technology to
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot